Digital healthcare firm Higgs Boson Health, a Durham-based portfolio company of the North Carolina Biotechnology Center, has been acquired by Globus Medical. Higgs Boson Health's technology and staff ...
NCBiotech's Military Outreach and Veterans Engagement (MOVE) Boots to Biotech program connects transitioning service members, ...
“Miracle Road” is the quintessential diary of what, how, and especially who made RTP what it is today, with some closing ...
Cambrex’s inspection approvals follow the company’s $38 million expansion of the High Point facility completed in 2023. The ...
By all accounts, the approach works. QHP has $4.5 billion in assets under management, and its newest fund, the NovaQuest ...
Innatrix Inc., a Durham-based agricultural biotechnology company developing sustainable biological crop protection solutions, ...
North Carolina’s life sciences industry has grown to include 860 companies statewide that employ 76,000 North Carolinians, ...
In addition to its new USPTO community engagement office, North Carolina has two libraries designated as Patent and Trademark Resource Centers: one in Raleigh and one in Charlotte. Though not part of ...
Chrysalis also announced its first platform partner: Plakous Therapeutics, a regenerative medicine company developing novel biologics to address critical unmet needs in neonatal diseases. Plakous, ...
Join Innovate Carolina on September 10 for a seminar discussing NCInnovation's grant program for faculty innovators.
We won't track your information when you visit our site. But in order to comply with your preferences, we'll have to use just ...
Eight of the top 10 largest pharma companies (based on 2025 revenue) will have operations in North Carolina, including AbbVie, AstraZeneca, Johnson & Johnson, Lilly, Merck, Pfizer, Roche/Genentech and ...